Common factors are thought to control vascular and neuronal patterning. Here we report an in vivo requirement for the vascular endothelial growth factor receptor type 2 (VEGFR2) in axon tract formation in the mouse brain. We show that VEGFR2 is expressed by neurons of the subiculum and mediates axonal elongation in response to the semaphorin (Sema) family molecule, Sema3E. We further show that VEGFR2 associates with the PlexinD1/Neuropilin-1 (Nrp1) receptor complex for Sema3E and becomes tyrosine-phosphorylated upon Sema3E stimulation. In subicular neurons, Sema3E triggers VEGFR2-dependent activation of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway that is required for the increase in axonal growth. These results implicate VEGFR2 in axonal wiring through a mechanism dependent on Sema3E and independent of vascular endothelial growth factor (VEGF) ligands. This mechanism provides an explanation as to how a semaphorin can activate an axon growth promoting response in developing neurons.
INTRODUCTION
The accurate wiring of the nervous system depends on the ability of axons to extend from neuronal somata to reach their distant targets. Recent evidence indicates that factors involved in the development and physiology of the vascular system are potential regulators of axonal growth. One example is the vasoconstrictive peptide endothelin-3, which acts through the endothelin-A receptor to promote axon extension (Makita et al., 2008) . In addition, a number of studies have described expression of well-known regulators of vascular network formation, the three VEGF ligand receptors (VEGFR1-3), in neuronal cells of the developing nervous system (Hashimoto et al., 2003; Kim et al., 2007; Le Bras et al., 2006; Yang et al., 2003) . To date, however, there has been no information regarding the ability of VEGF receptors to govern axonal patterning in vivo.
The type III receptor tyrosine kinase (RTK) VEGFR2 (also known as kinase insert domain protein receptor [KDR] or fetal liver kinase 1 [Flk1]) is the major receptor for VEGF (or VEGF-A). In vitro, VEGF has been reported to act via VEGFR2 to promote neurogenesis, neuronal survival and axon outgrowth (reviewed in Raab and Plate, 2007) . However, the intricate relationship between nervous and vascular cells has made it difficult to distinguish whether the in vivo effects of VEGF on neuronal development were direct or indirect (i.e., secondary to vascular defects). Clear evidence for a direct function of VEGF/VEGFR2 signaling in neuronal development has been provided by studies of neurogenesis in the avascular embryonic retina (Hashimoto et al., 2003) and in the adult brain (Cao et al., 2004; Wittko et al., 2009) . In contrast, in the embryonic cerebral cortex, lowering VEGF levels indirectly causes a decrease in cell proliferation associated with neuronal degeneration, as a result of inappropriate brain vascularization (Haigh et al., 2003) . Indeed, no major structural brain abnormalities have been reported in neural cell-specific Vegfr2-deficient mice (Haigh et al., 2003) , indicating that neuronal VEGFR2 is unlikely to directly mediate the mitogenic and neurotrophic effects of VEGF during brain development. The exact function of neuronal VEGFR2 in the developing brain so far remains to be discovered.
When exploring the role of VEGFR2 in the developing mouse brain, we found that VEGFR2 is expressed by neurons of the subiculum, a subregion of the hippocampal formation, which extend efferent projections through the postcommissural fornix tract (Kishi et al., 2000) . Conditional deletion of Vegfr2 in neural cells results in delayed formation and marked reduction in size of the postcommissural fornix, suggesting that VEGFR2 is required to control subicular axon growth in vivo. In our search for growth-regulating cues acting through VEGFR2, we found that VEGF ligands have little or no effect on subicular axon growth in vitro. Instead, blocking VEGFR2 function in subicular neurons impedes axonal response to the guidance molecule Sema3E, which is required for the proper development of the postcommissural fornix pathway (Chauvet et al., 2007) . We provide further evidence that VEGFR2 associates with the PlexinD1/Neuropilin-1 (Nrp1) receptor complex for Sema3E (Chauvet et al., 2007) and transduces Sema3E growthpromoting signal. Taken together, the results of this study identify a VEGF-independent function of VEGFR2 as a co-receptor for the guidance molecule Sema3E and a regulator of axonal growth in the developing nervous system.
RESULTS

VEGFR2 Expression Delineates the Subiculo-mamillary Axon Pathway
To begin to assess the function of VEGFR2 in the developing nervous system, we analyzed the profile of VEGFR2 protein expression on sections of embryonic day (E) 17.5 mouse heads, focusing on the forebrain. Blood vessels supplying the brain expressed VEGFR2 and coexpressed the endothelial marker PECAM-1 (platelet endothelial adhesion molecule-1; Figures  1B-1J) . A lower level of VEGFR2 expression was detected along the trajectory of a subset of fiber tracts that are negative for PECAM-1 immunostaining and express the axonal marker L1 ( Figures 1K-1M ). Among these were fibers coursing through the fimbria (fim; Figures 1B-1D ), fornix (f; Figures 1E-1G ) and postcommissural fornix (pf; Figures 1H-1J ). To identify these projections, we compared the profile of VEGFR2 expression with that of PlexinD1 and Nrp1, two markers of axons from the subiculum that project through the fornix and postcommissural fornix to the mamillary bodies in the hypothalamus (Chauvet et al., 2007) . We found that virtually all VEGFR2-immunopositive (A) Schematic representation of the path taken by subiculo-mamillary projections in red, from the subiculum (Sub) through the fimbria (fim), fornix (f), and postcommissural fornix (pf). Before birth, axons in the postcommissural fornix extend beyond the mamillary bodies (mb), which are innervated by interstitial axon collaterals during the first postnatal weeks (Stanfield et al., 1987) . (B-J) Immunolabeling of VEGFR2 (B, E, and H) and PECAM-1 (C, F, and I) on coronal sections of wild-type brain at E17.5. Expression of VEGFR2 is apparent throughout the subiculo-mamillary projection, in the fimbria (fim in B and D), fornix (f in E and G), and postcommissural fornix (pf in H and J). axons also expressed PlexinD1 ( Figures 1N-1P ) and Nrp1 . Triple staining for VEGFR2, PlexinD1, and Nrp1 was not possible due to lack of appropriate antibodies. However, given the fact that PlexinD1 and Nrp1 are known to be coexpressed on subicular projections (Chauvet et al., 2007) , these data strongly support the idea that all three proteins are expressed in subicular axons. Moreover, Vegfr2 mRNA was detected in the pyramidal layer of the subiculum at E17.5 (data not shown), as previously described in the prenatal rat brain (Kim et al., 2007) . Together, these results indicate that VEGFR2 is present on projection neurons of the subiculum at a stage when the subiculo-mamillary pathway has begun to form (see scheme in Figure 1A ). Finally, we also found that some VEGFR2-positive cells within the fimbria were co-labeled with antibodies against the glial fibrillary acidic protein (GFAP), indicating that VEGFR2 is also expressed by astrocytes ( Figures  1T-1V ).
Neural Expression of VEGFR2 Controls the Development of the Postcommissural Fornix
To determine whether VEGFR2 is required in neurons and/or nonneuronal glia cells to pattern neuronal projections, we set out to analyze mouse embryos bearing a nervous systemspecific deletion of Vegfr2-induced by Nestin promoter driven Cre recombinase (Haigh et al., 2003; see Experimental Procedures Figures S1C-S1E) .
To examine the impact of VEGFR2 expression on neuronal connectivity, we injected DiI into the subiculum of neural cellspecific Vegfr2 null embryos and control embryos at E17.5 and monitored the pattern of subiculo-mamillary projections. In Vegfr2 conditional mutants, although many labeled fibers entered the fornix (defined here as ''0 mm; '' Figures 2B and 2K) , the caudal extent of the postcommissural fornix was reduced and axons failed to project into the posterior-most region of the hypothalamus, (''+600 mm''; phenotype observed in In neural cell-specific Vegfr2 knockout embryos, the development of the subicular projections is massively delayed and no fibers reach the caudal hypothalamus at E17.5. f, fornix; pf, postcommissural fornix, Sub, subiculum; mb, mamillary bodies. Scale bars, 100 mm (A-D), 150 mm (E and F), 70 mm (G and H), 5 mm (I and J). See also Figure S1 . Figures 2N and 2O ). This phenotype was also apparent with another marker of subiculo-mamillary projections, PlexinD1 ( Figures 2E and 2F ). The position of the growth front of DiI-labeled axons did not correlate with a particular anatomical structure and varied among individual animals, with Vegfr2 lox/-; Cre mutants being generally the most severely affected ( Figure 2K ). Importantly, postcommissural tract positioning appeared normal, and no ectopically labeled axons were detected in mutant embryos (not shown). The number of neurons in the subiculum was unchanged in mutant embryos ( Figures S1F-S1K ), suggesting that cell death in the subiculum is unlikely to account for the reduced postcommissural pathway in Vegfr2 conditional knockout embryos. In addition, Vegfr2 conditional mutants have a normal distribution of Sema3e, Plxnd1, and Nrp1, which have been previously shown to regulate subicular axon outgrowth (Chauvet et al., 2007 ; Figure S1L ).
To explore further the influence of VEGFR2 on subiculo-mamillary projections, we used neurofilament immunostaining to study the morphology of the postcommissural tract in postnatal day (P) 30 neural cell-specific Vegfr2 null mice. Mutant mice exhibit a hypoplastic postcommissural tract, with a crosssectional area $30% smaller than control animals (phenotype observed in 3/3 Vegfr2 lox/lox ;Cre mice; 2/2 Vegfr2 lox/-;Cre mice and 0/4 control mice; Figures 2G, 2H , and 2L). The density of axons within the postcommissural tract remained unchanged between the control and mutant animals, indicating fiber loss in Vegfr2 mutants ( Figures 2I, 2J , and 2M). These findings show that neural expression of VEGFR2 is necessary for formation of the postcommissural pathway, and that the early reduction in postcommissural fornix projections observed in Vegfr2 mutant embryos is reflected by a thinner axon tract at later stages.
VEGFR2 Is Necessary for Sema3E-Mediated Growth Promotion and Attraction of Subicular Axons
The reduced growth of the subiculo-mamillary projections in Vegfr2 conditional mutants suggests that VEGFR2 may act as a surface receptor for environmental growth-promoting signals.
To test this, we cultured dissociated neurons from the subiculum and measured the effect of known VEGFR2 ligands, namely VEGFA 164 , VEGFA 120 , VEGFC, and VEGFD, on axonal elongation after 2 days in vitro. Cultured subicular neurons express VEGFR2, as assessed by RT-PCR and immunostaining ( Figures  3A and 3B ). The growth of subicular axons was not affected by VEGFA 164 , VEGFC, and VEGFD, while axonal length was decreased by $20% in the presence of VEGFA 120 compared to control conditions ( Figure S2A ). These results indicate that signaling by VEGF ligands is unlikely to promote elongation of subiculo-mamillary axons in the developing brain.
We previously demonstrated that mice deficient for Sema3E exhibit hypoplasia of the postcommissural fornix tract (Chauvet et al., 2007) , a phenotype similar to that of neural cell-specific Vegfr2 null mice. We therefore examined whether VEGFR2 is required in subicular axons to respond to Sema3E. As previously reported (Chauvet et al., 2007) , the mean length of subicular axons is increased by 37% in the presence of 5nM Sema3E ( Figures 3C and 3D ). Applying antibodies directed against the extracellular domain of VEGFR2 or selective VEGFR2 kinase inhibitors, SU1438 and Ki8751, completely abrogated the growth-promoting effect of Sema3E ( Figures 3C-3F ). The same result was obtained after electroporation of subicular neurons with siRNA sequences that decrease VEGFR2 expression ( Figures 3G, 3H , and S2G-S2I). Finally, subicular neurons obtained from Vegfr2 lox/-;Cre mutant embryos demonstrated a complete loss in their growth response to Sema3E treatment (Figures 3I and 3J) .
We next tested the response of subicular axons in an in vitro assay for directional guidance, where subicular explants are cultured next to HEK293T cell aggregates secreting Sema3E. Normally, subicular explants develop a dense outgrowth of axons directed toward the source of Sema3E (Figures 3K and 3L) . In contrast, axon outgrowth from explants from Vegfr2 conditional mutants occurred in all directions with no preferential orientation despite the presence of Sema3E-expressing cells (Figures 3K and 3L) . Together, these observations argue for a role of VEGFR2 in subicular axon responsiveness to the growth-promoting and chemoattractive activities of Sema3E.
VEGFR2 Expression in Cortical Neurons Is Required for Stimulation/Attraction but Not Inhibition/Repulsion of Axon Growth by Sema3E
In contrast to neurons from the subiculum, neurons from the ventrolateral cortex show reduced axonal growth and axon repulsion in the presence of Sema3E (Figures S2B and S2E ). Although cultured dissociated cortical neurons express VEGFR2 ( Figure 3B ), blocking VEGFR2 using neutralizing antibodies, chemical inhibitors, or siRNAs did not affect their normal growth inhibitory response to Sema3E (Figures S2B-S2D ). In addition, cortical neurons from Vegfr2 lox/-;Cre mutant embryos extended shorter axons in the presence of recombinant Sema3E ( Figures  3M and 3N ) and grew preferentially away from HEK293T cell aggregates expressing Sema3E ( Figure S2E ), demonstrating that VEGFR2 is not required for inhibition and repulsion.
We previously reported that exposure of cortical neurons to Nrp1-Fc, encoding the extracellular domain of Nrp1 fused to a human Fc immunoglobulin domain, is sufficient to switch growth inhibition in response to Sema3E to growth promotion (Chauvet et al., 2007) . Here we found that silencing of VEGFR2 in cortical neurons using siRNA prevented stimulation of axonal growth by Sema3E in the presence of Nrp1-Fc ( Figure S2F ). The same Blockade of VEGF has no effect on axon growth promotion by Sema3E. Data are presented as mean axonal length ± SEM (n = 3) and are normalized to 100% for values obtained in control conditions. (C) Typical images of dissociated subicular neurons cultured in the presence or absence of 5 nM Sema3E and of VEGFA 164 (10 to 100 nM). (D) Quantification of the results illustrated in (C). At high concentration, exogenous VEGFA 164 partially diminishes the axonal growth response to Sema3E. ***significantly different with p < 0.001. Scale bars, 25 mm.
conclusion was drawn from analysis of cortical neurons from Vegfr2 lox/-;Cre mutants treated with Nrp1-Fc ( Figures  3M and 3N ). Thus, VEGFR2 is a necessary component of Sema3E signaling mechanism for axon growth-promotion/attraction, but not growthinhibition/repulsion.
Sema3E Growth Activity Is Independent of VEGF Ligands
We next examined whether VEGFR2-specific ligands and Sema3E could functionally cooperate in a subicular axon growth assay. We found that applying an anti-VEGF antibody that neutralizes VEGFA 120 and VEGFA 164 bioactivities in the culture medium of subicular neurons did not affect axonal growth induced by Sema3E ( Figures 4A and 4B) . Furthermore, addition of increased concentrations of recombinant VEGFA 164 (10 nM-100 nM) to dissociated subicular neurons did not potentiate the growth response of subicular neurons to Sema3E. Rather, we observed a partial but incomplete blocking of Sema3E-induced axonal growth when VEGFA 164 was added at a high concentration (100 nM) ( Figures 4C and 4D) . Thus, VEGFR2 ligands are not required for Sema3E growth-promoting activity, although excess of VEGF may modulate Sema3E signaling, likely via a competitive mechanism for VEGFR2 function.
A PlexinD1/Nrp1/VEGFR2 Receptor Complex for Sema3E
The above results indicate that VEGFR2 participates in axon growth-promotion by Sema3E via a mechanism independent of VEGF, raising the possibility that VEGFR2 is part of a receptor complex for Sema3E. We have previously demonstrated that Sema3E-induced growth of subicular axons requires cooperative interaction between PlexinD1, the binding partner for Sema3E, and its coreceptor Nrp1 ( Figure 5A ; Chauvet et al., 2007) . A possible interaction between VEGFR2 and PlexinD1 was first investigated by coimmunoprecipitation of epitope-tagged proteins in transfected HEK293T cells. As shown in Figure 5A , VEGFR2 coimmunoprecipitated with PlexinD1 in a ligand-independent fashion. Using a triple-immunoprecipitation approach in HEK293T cells expressing PlexinD1, Nrp1, and VEGFR2, we demonstrated that all three proteins coprecipitated in both absence and presence of Sema3E ligand ( Figures 5A and 5B) , suggesting the formation of a trimeric complex. We next showed that full length VEGFR2 is able to interact with cytoplasmic deleted versions of PlexinD1 (PlexinD1DC) and/or Nrp1 (Nrp1DC), indicating that the assembly of PlexinD1/Nrp1/ VEGFR2 complex is mediated through extracellular interactions ( Figure S3A ). To further demonstrate that Sema3E interacts with this tripartite complex, Sema3E was immunoprecipitated from culture supernatants of alkaline phosphatase (AP) tagged Sema3E-transfected HEK293T cells using an anti-AP antibody and incubated with a lysate of HEK293T cells co-expressing VEGFR2, PlexinD1, and Nrp1. As shown in Figure 5C , APSema3E precipitated all three partners of the putative receptor complex. The recovery of Nrp1 and VEGFR2 in ligand-receptor complexes can not be explained by a direct interaction with this semaphorin, since AP-Sema3E fusion protein did not bind to HEK293T cells expressing Nrp1 and/or VEGFR2 ( Figure 5D ). Surface expression of Nrp1 and VEGFR2 was confirmed in these experiments using an AP-VEGFA 164 fusion protein ( Figure 5D ). In contrast, AP-Sema3E was able to bind to cells expressing the known Sema3E binding receptor, PlexinD1, either alone of in combination with Nrp1 and VEGFR2 cointeractors ( Figures 5D  and S3B ). Taken together, our findings support a model in which Sema3E binds to a preassociated PlexinD1/Nrp1/VEGFR2 receptor complex on the cell surface, with PlexinD1 serving as the ligand-binding subunit.
VEGFR2 Is Activated upon Sema3E
Binding to PlexinD1/Nrp1/VEGFR2 Receptor Complex We next sought to determine whether Sema3E could induce VEGFR2 kinase activation. For this, HEK293T cells expressing VEGFR2, either alone or in combination with PlexinD1 and Nrp1, were treated with Sema3E (10 nM) and the phosphorylation level of VEGFR2 was analyzed using phosphospecific antibodies to Tyr1175 (corresponding to Tyr1173 in murine VEGFR2) and Tyr1214 (corresponding to Tyr1212 in murine VEGFR2), the two major autophosphorylation sites on the cytoplasmic region of VEGFR2 (Takahashi et al., 2001 ). Overexpressed VEGFR2 was basally phosphorylated in HEK293T cells. As shown in Figures 5E-5G , Sema3E stimulation did not affect tyrosine phosphorylation of VEGFR2 in cells transfected with VEGFR2 alone. However, an increased phosphorylation at Tyr1173/1175 and Tyr1212/1214 was detected in cells coexpressing VEGFR2 and the binding receptor for Sema3E, PlexinD1 (Figures 5E-5G) . Interestingly, Sema3E induced maximal phosphorylation of VEGFR2 in cells expressing the three proteins, VEGFR2, PlexinD1, and Nrp1 ( Figures  5E-5G ). Together, these findings support the idea that VEGFR2 is an additional component of Sema3E receptor complex and that VEGFR2 can be indirectly activated through Sema3E binding.
VEGFR2 Is the Signal-Transducing Subunit in the Sema3E Receptor Complex
The finding that VEGFR2 associates with PlexinD1 and Nrp1 and that all three proteins are required for Sema3E-mediated axon growth promotion raises questions about the respective function of each protein in Sema3E signaling. Interestingly, in experiments using Nrp1DC to rescue siRNA-mediated silencing in subicular neurons, we observed that the cytoplasmic domain of Nrp1 is not required for the growth-promoting response of subicular axons to Sema3E in vitro ( Figures 6A and 6B ). This is consistent with our early studies showing that the ''gating'' activity of Nrp1, which switches Sema3E signaling from inhibition to growth promotion, is encoded in the extracellular domain of Nrp1 (Chauvet et al., 2007) . Here we found that the MAM (Meprin/A5-protein/PTPmu) domain of Nrp1 is both necessary and sufficient to exert this gating function ( Figures S4A-S4C ). Perhaps more surprising was the finding that the cytoplasmic domain of PlexinD1 is not required either for the stimulatory activity of Sema3E. Indeed, the response of subicular neurons to Sema3E was completely lost after treatment with a siRNA to PlexinD1 ( Figures 6C and 6D and Figures S4D-S4F ) but was restored in neurons re-expressing PlexinD1DC ( Figures 6C  and 6D ). These findings indicate that, although PlexinD1 serves as a binding molecule for Sema3E, it does not transduce Sema3E signal in subicular neurons and point to a role of VEGFR2 in transmitting the Sema3E growth-promoting signal. To assess this, we knocked down VEGFR2 in cultured neurons from the subiculum and performed rescue experiments with full length VEGFR2 or a signaling-defective VEGFR2 mutant (VEGFR2 Y1175F ). Substitution of tyrosine residue 1175/1173 with phenylalanine is sufficient to abrogate VEGFR2 function both in vitro and in vivo (Holmqvist et al., 2004; Sakurai et al., 2005; Takahashi et al., 2001) . As shown in Figures 6E and 6F , full length VEGFR2 successfully restored sensitivity of subicular neurons to Sema3E. In contrast, subicular axons expressing VEGFR2 Y1175F did not show increased elongation following Sema3E stimulation ( Figures 6E and 6F) . These results strongly suggest that VEGFR2 is the signal-transducing subunit in the PlexinD1/Nrp1/VEGFR2 receptor complex for Sema3E.
Sema3E Stimulates Axon Growth through VEGFR2-Mediated Activation of the PI3K/Akt Pathway
The above results demonstrate an essential function of Tyr1173/ 1175 in VEGFR2 during Sema3E-mediated axon elongation. Studies of endothelial cell signaling have reported that Tyr1173/1175 is important for VEGF-induced activation of PI3K leading to endothelial cell migration (Holmqvist et al., 2004) . Since the PI3K pathway is known to be related to axon growth (Cosker and Eickholt, 2007; Kim et al., 2006) , we sought to determine whether PI3K-dependent signaling is implicated in Sema3E-mediated axonal outgrowth. We first examined the effect of Sema3E on endogenous Akt activity, a downstream target of PI3K, in cultures of subicular neurons. We found that Sema3E stimulation caused a marked increase in phosphorylated (p)-Akt ( Figures S5A and S5C ). In contrast, in control experiments with cortical neurons, endogenous levels of p-Akt were decreased on Sema3E treatment ( Figures S5B and S5C) . We next investigated whether Sema3E promotes axon growth through the PI3K pathway. Sema3E-induced subicular axon growth was abolished by the PI3K inhibitors, LY294002 and wortmannin ( Figures 7A and 7B ) and upon dominant-negative PI3K transfection in cultured neurons ( Figures 7E and 7F) . Similarly, inhibition of Akt using RNA interference ( Figures 7C,  7D , and S5D) or a dominant-negative Akt mutant ( Figures 7E  and 7F ) suppressed Sema3E-mediated growth of subicular axons. Finally, constitutive activation of glycogen synthase kinase-3-beta (GSK-3b), inactivation of which is catalyzed by Akt, also inhibited the effect of Sema3E on subicular axon growth ( Figures 7E and 7F) . Together, these results suggest that activation of PI3K and Akt, leading to inactivation of GSK-3b, is required for Sema3E-induced axonal growth.
We next investigated whether activation of the PI3K pathway on Sema3E treatment was mediated by VEGFR2. To this aim, we used antibodies that specifically detect p-Tyr1173/1175 in VEGFR2, p-Akt and p-GSK-3 to perform quantitative immunofluorescence on growth cones from cultured subicular neurons stimulated with Sema3E. As expected, stimulation with Sema3E (10 nM) caused a significant increase in p-Tyr1173/1175, p-Akt, and p-GSK-3 compared to unstimulated growth cones ( Figures  7G and 7H ). Ki8751, a selective inhibitor of VEGFR2 tyrosine kinase that inhibited Sema3E induced growth promotion (see Figures 3E and 3F ), blocked these increases ( Figures 7G and  7H ), suggesting that Sema3E-induced activation of the PI3K pathway is mediated via VEGFR2 signaling.
Reconstructing a Functional Signaling Receptor for Sema3E Growth Promotion
Our above results suggest that the receptor mediating Sema3E growth-promoting activity is a multisubunit structure comprising VEGFR2, PlexinD1 and Nrp1. To directly test our model, we examined whether coexpressing these proteins in cultured neurons from E14.5 thalamus, which expresses undetectable levels of Plxnd1, Nrp1, and Vegfr2 ( Figure S6 ), was sufficient to reconstitute a functional Sema3E receptor complex mediating Figure S4 .
growth promotion. As shown in Figures 8A and 8D , the length of thalamic neurons transfected with a control vector encoding GFP was unaffected by the addition of Sema3E. When expressed alone or in combination, VEGFR2 and Nrp1 did not allow thalamic axons to respond to Sema3E ( Figures 8A and 8D) , which is in accordance with the fact that neither VEGFR2 nor Nrp1 directly interact with Sema3E. In contrast, expression of PlexinD1 conferred sensitivity to the inhibitory activity of Sema3E and thalamic axons showed reduced outgrowth upon Sema3E stimulation (Figures 8B and 8D, scheme in 8E) . This is consistent with the proposed function of PlexinD1 as ligand-binding and signal-transducing receptor in Sema3E inhibitory/repulsive (G) Immunolabeling of growth cones from growing subicular neurons using anti-phosphotyrosine antibody to Tyr1173/1175 in VEGFR2 (apY1175VEGFR2) or anti-phospho-Akt antibodies (apAkt) or anti-phospho-GSK-3 antibodies (apGSK3). Growth cones were treated 5 min with 10 nM of Sema3E in presence or absence of 10 mM VEGFR2 inhibitor (Ki8751). Sema3E induces phosphorylation of VEGFR2, Akt and GSK-3, in a VEGFR2-dependent manner.
(H) Quantification of the immunostaining illustrated in (G). The values represent the mean pixel intensity of apY1175VEGFR2, apAkt, and apGSK3 staining within growth cones (see Experimental Procedures). ***significantly different with p < 0.001. Scale bars, 25 mm (A, C, and E), 7 mm (G). See also Figure S5 .
signaling (Chauvet et al., 2007; Gu et al., 2005; Uesugi et al., 2009) . Interestingly, while coexpression of VEGFR2 had no effect on PlexinD1-mediated growth inhibition, the response of thalamic neurons to Sema3E was abolished when PlexinD1 was coexpressed with Nrp1 ( Figures 8B and 8D ). This suggests a specific function of Nrp1 in inhibiting PlexinD1 signaling and further indicates that dimerization of PlexinD1 with either Nrp1 or VEGR2 is not sufficient to induce growth promotion. Indeed, coexpressing PlexinD1 with Nrp1 and VEGFR2 was necessary to cause thalamic axons to grow longer in response to Sema3E stimulation ( Figures 8C, 8D , and scheme in 8F), confirming that the presence of all three components is required for Sema3E-mediated growth promotion. To further show that VEGFR2 is responsible for signal transduction, we expressed full-length VEGFR2 with PlexinD1DC and Nrp1DC in thalamic neurons. As expected, transfected neurons exhibited increased axonal elongation in response to Sema3E ( Figures 8C, 8D , and scheme in 8G), and this effect was abrogated by expressing the signalingdefective mutant VEGFR2 Y1175F together with PlexinD1DC and Nrp1DC ( Figures 8C, 8D , and scheme in 8H). Thus, these results (E-H) Molecular models for axonal growth responses to Sema3E. Sema3E inhibits axonal growth of neurons which express PlexinD1 alone (E). In contrast, axons of neurons expressing VEGFR2, PlexinD1, and Nrp1 show a growth promoting response to Sema3E (F). The intracellular domain of VEGFR2 is required to mediate the growth response to Sema3E (G and H), indicating that VEGFR2 is the signal transducing subunit of the complex. ***significantly different with p < 0.001. Scale bars, 20 mm (A-C). See also Figure S6. support a model in which VEGFR2 is the component of the receptor complex linking Sema3E to a signal transduction pathway driving axonal outgrowth.
DISCUSSION
Neuronal VEGFR2 Is Required for Axon Growth and Neuronal Projections Our findings identify a critical role of neural VEGFR2 in the establishment of a major axon tract, which plays important functions in memory and emotional behavior (O'Mara, 2005) . First, we show that VEGFR2 is expressed in axons along the developing subiculo-mamillary pathway. Second, we report that VEGFR2 deficiency in neural cells leads to reduced growth of subiculomamillary axons in the mouse embryonic brain. Since VEGFR2 is also detected in a small population of GFAPpositive glia cells located in the fimbria, we were concerned that defects in subiculo-mamillary projections might reflect the loss of protein expression in these cells, which are also affected by Nestin Cre-mediated deletion of VEGFR2, rather than in axons. Indeed, vertebrate glia cells require members of the VEGF and VEGF receptors family for their proliferation (Forstreuter et al., 2002; Le Bras et al., 2006) . Moreover, loss of function of PVR, the platelet-derived growth factor receptor (PDGFR)/VEGFR homolog in Drosophila, causes defects in commissural axon development that are secondary to a reduction in midline glia number (Learte et al., 2008 ). Here we observed that the subiculo-mamillary axons pathfind normally through the fimbria/ fornix in Vegfr2 conditional mutants, making it unlikely that VEGFR2-expressing glia cells underlie the phenotype observed in the postcommissural portion of the tract. Our results support the view that axonal expression of VEGFR2 mediates a positive effect on the growth and guidance of subiculo-mamillary projections. This is supported by in vitro findings showing that VEGFR2 is required cell autonomously for subicular neurons to respond to Sema3E, a factor essential for the development of a functional subiculo-mamillary projection (Chauvet et al., 2007) . In vivo, a plausible source of Sema3E is provided by the axons of pyramidal neurons from field CA1 and CA3 of Ammon's horn, which express Sema3e mRNA (Chauvet et al., 2007) . Like the subiculum, field CA1 projects massively through the fimbria/fornix, and the ventral pole of CA1 also contributes to the postcommissural input to the caudal hypothalamus (Cenquizca and Swanson, 2006) . We therefore propose a model involving VEGFR2 expression by subicular axons in the recognition mechanism of the attractive/growth-promoting factor Sema3E, supplied locally along the subiculo-mamillary pathway by CA1 axons.
We found persistent defects, albeit less pronounced than in embryos, of the subiculo-mamillary projections in P30 Vegfr2 mutant mice, with the postcommissural fornix axon tract being thinner and containing fewer fibers than the same tract from a control animal. Thus, whereas initial projections from the subiculum failed to grow into the caudal hypothalamus at E17.5, a significant number of subiculo-mamillary axons reach their target field at a later stage of development. In one simple scenario, the absence of VEGFR2 signaling just decreases the rate of axonal growth and delays the eventual formation of the postcommissural fornix tract. The reduced tract size may reflect some other defects, such as neuronal cell death in the absence of target contact at the appropriate time or additional impairments in axon growth in the subiculo-mamillary pathway. Alternatively, the transient absence of a postcommissural axon tract may be corrected by later projecting neurons that do not depend on VEGFR2 signaling for their development.
In the course of our study, we observed axonal expression of VEGFR2 in other sites of the developing brain, notably in the intermediate zone of the cerebral cortex (data not shown). Neurofilament staining on sections through the anterior brain of neural-specific Vegfr2 mutant embryos did not reveal major defects in cortical projections. However, this does not exclude the possibility of subtle abnormalities, and further studies will determine whether neural VEGFR2 is required for wiring neuronal connections outside the hippocampal formation.
Role of Plexin-Associated VEGFR2 in Transduction of Sema3E Growth Activity Several arguments identify VEGFR2 as a transmembrane subunit of a trimeric PlexinD1/Nrp1/VEGFR2 receptor complex for Sema3E. First, we found that VEGFR2 is present with PlexinD1 and its coreceptor Nrp1 in subicular axon projections in vivo and all three proteins physically interact when expressed in a heterologous system. Second, exposure to Sema3E resulted in VEGFR2 tyrosine phosphorylation in subicular growth cones and in heterologous cells in a PlexinD1-and Nrp1-dependent manner. Finally, the cooperative effects of VEGFR2, PlexinD1, and Nrp1 proteins is required to mediate Sema3E axon outgrowth activity on different types of neurons, including neurons from the subiculum, cortex and thalamus.
A number of RTKs has been previously shown to associate in receptor complexes with particular plexins (reviewed in Franco and Tamagnone, 2008) , but the mechanism by which they contribute to semaphorin signaling is still largely obscure. It has been proposed, although not demonstrated, that RTKdependent phosphorylation of plexins on tyrosine residues might create docking sites or induce conformational change of the plexin C-terminal tail, thus allowing the recruitment of specific signaling effectors to plexin receptors (Franco and Tamagnone, 2008) . However, in our system, we failed to detect tyrosine phosphorylation of PlexinD1 following Sema3E-mediated activation of VEGFR2 (data not shown). Moreover, we observed that, even though PlexinD1 is required for the effect of Sema3E on subicular neurons, its cytoplasmic domain is dispensable. Our results rather support a mechanism in which Sema3E initiates intracellular signaling through VEGFR2, independently of PlexinD1 signaling. Evidence for this model comes from experiments showing that expression of VEGFR2 with PlexinD1DC and Nrp1DC proteins was sufficient to reconstitute a functional receptor for growth-promoting Sema3E in heterologous cells.
The ability of VEGFR2 to signal axon growth promotion is further supported by studies of the signaling cascade downstream of Sema3E, which define an important role of the PI3K/ Akt/GSK-3b pathway. Interestingly, we report that pharmacological inhibition of VEGFR2 kinase activity blocked Sema3E-induced phosphorylation of Akt and GSK-3b in growth cones of subicular neurons, and that the VEGFR2 Y1175F mutant, which displays reduced PI3K activation (Meyer et al., 2003; Rahimi et al., 2000) , is unable to mediate efficient Sema3E outgrowth activity. Together, these results indicate that VEGFR2 acts as an upstream regulator of the PI3K signaling pathway. Several adaptor proteins such as VRAP (VEGF receptor associated protein), Gab1 (Grb2-adaptor binder 1), and SHB has been reported to promote PI3K activation downstream of VEGFR2 in endothelial cells (Holmqvist et al., 2004; Wu et al., 2000) . Further studies will determine whether these proteins are also used in neurons for Sema3E response and how they allow for effective coupling of VEGFR2 to PI3K.
Role of Nrp1 in Sema3E-Induced Axonal Growth Promotion Although VEGFR2 function is specifically required for the outgrowth-promoting activity of Sema3E, it is expressed both in subicular neurons, which show a positive growth response to Sema3E, and in cortical neurons, whose growth is inhibited by Sema3E. In fact, subicular neurons differ from cortical neurons in their expression of Nrp1, which appears to be the key determinant of the biological outcome of Sema3E signaling (Chauvet et al., 2007) . It is possible that Nrp1 expression controls neuronal VEGFR2 activity, as is the case in endothelial cells where Nrp1 functions as a co-receptor to enhance VEGFinduced VEGFR2 signaling (Kawamura et al., 2008; Soker et al., 1998) . Consistent with this idea, Sema3E-induced VEGFR2 phosphorylation was more effective in the presence than in the absence of Nrp1. Thus, in subicular neurons, Nrp1 likely contributes to enhance VEGFR2 activation to threshold levels for axon growth promotion. However, the fact that knocking down Nrp1 in subicular neurons not only blocks the Sema3E growth response but switches the response to growth inhibition suggests additional levels of complexity to signal regulation by Nrp1. We propose that Nrp1 is required in subicular neurons to maintain the PlexinD1 receptor in a non-signaling state, therefore preventing initiation of an inhibitory signaling cascade. The finding that thalamic neurons expressing only PlexinD1 elicited an inhibitory growth response to Sema3E and that coexpression of PlexinD1 and Nrp1 leads to loss of response to Sema3E argues in favor of this model. It is known that PlexinD1 inhibits axonal growth through endogenous R-Ras GTPase activating protein (GAP) activity (Uesugi et al., 2009 ). It will be important to determine whether Nrp1 inhibits R-Ras GAP activity downstream of PlexinD1. Such a possibility is consistent with the finding that Nrp1 modulates formation of PlexinA1 complexes with FARP2 and the Rnd1 GTPase, two important regulators of the R-Ras GAP activity (Toyofuku et al., 2005) .
Together, our data provide evidence for a model in which three transmembrane molecules, PlexinD1, Nrp1, and VEGFR2, cooperate to mediate the growth-promoting property of Sema3E, with Nrp1 switching the Sema3E signal from the ''growth-inhibitory'' receptor PlexinD1 to the ''growth-promoting'' coreceptor VEGFR2.
VEGFR2 Function in Subicular Axon
Growth Is Independent of VEGF Previous studies have explored interactions between semaphorins and VEGF signaling. In the cardiovascular system, semaphorins have been implicated as modifiers of the VEGF pathway, acting either as suppressors (Acevedo et al., 2008; Toyofuku et al., 2007) or enhancers of VEGF/VEGFR2 signaling (Toyofuku et al., 2004) . Inversely, in the nervous system, VEGF has been hypothesized to antagonize semaphorin signaling, therefore controlling the migration and survival of neuronal progenitor cells as well as axonal guidance (Bagnard et al., 2001; Carmeliet, 2003; Marko and Damon, 2008) . In the present study, however, we failed to demonstrate antagonistic/cooperative functions of Sema3E and VEGF in the promotion of axonal elongation. Furthermore, we observed that Sema3E, but not VEGFA 164 , stimulates growth of VEGFR2-expressing subicular axons. This result is consistent with previous works finding cell-type specificity for the use of either semaphorin or VEGF ligand during in vivo patterning events (Schwarz et al., 2004; Vieira et al., 2007) . In the future, it will be intriguing to determine the mechanisms underlying such ligand selectivity in VEGFR2-mediated responses. Several hypotheses can be considered. Glycosaminoglycan (GAG) modification of Nrp1 might negatively regulate VEGFA 164 activity in subicular neurons, as reported in smooth muscle cells (Shintani et al., 2006) . Alternatively, differences in modes of VEGFR2 activation on Sema3E or VEGF stimulation may cause differences in the magnitude of the signals and/or coupling to downstream signaling pathways, thus leading to distinct functional outcomes. Our results do not exclude, however, that VEGF/VEGFR2 signaling may play a role in the patterning of neuronal projections in regions of the nervous system other than the postcommissural tract in the mouse.
Conclusion
Recent evidence indicates similarities in the mechanisms that orchestrate the development of the nervous and vascular systems both at the cellular and molecular levels (reviewed in Carmeliet and Tessier-Lavigne, 2005; Larrivé e et al., 2009) . So far, members of all four classical families of axon guidance molecules (semaphorins, slits, ephrins, and netrins) and their cognate receptors have been implicated in vascular morphogenesis. Our findings present evidence for the reverse situation, in which the well-known angiogenic receptor VEGFR2 appears to be critical for neuronal projections by regulating axonal growth both in vitro and in vivo. Furthermore, our results implicate VEGFR2 in relaying signaling of the growth factor Sema3E, independently of its preferential VEGF ligands, revealing a novel interplay between molecular actors of neuronal and vascular development.
EXPERIMENTAL PROCEDURES Animals
Nestin-Cre conditional and null Vegfr2 mice lines have been previously reported (Haigh et al., 2003 , and Cre negative controls that were used in the analysis. The genotype of the offspring was determined by PCR as described (Haigh et al., 2003) .
Immunohistochemistry
Immunohistochemistry on brain sections was carried out following standard procedures. Details on antibodies can be found in Supplemental Experimental Procedures.
Production of AP-Tagged Proteins and Binding Assay
Production of mouse AP-Sema3E and AP-VEGF164 and binding experiments on HEK293T cells were performed as described previously (Chauvet et al., 2007; Feiner et al., 1997) . The mouse AP-VEGF 164 construct was a gift from U. Felbor.
Explant Coculture Experiments and Dissociated Neuronal Cultures
Brains from wild-type CD1 or Vegfr2 lox/-(Control) or Vegfr2 lox/-;Cre mutants embryos were dissected to extract subiculum and ventrolateral cortex at E17.5, or thalamus at E14.5. Cocultures with HEK293T cell aggregates and dissociated cultures were performed as described in Chauvet et al. (2007) . In some experiments, neurons were electroporated with a GFP-pCAGGS vector alone or together with expression vectors encoding Flag-VEGFR2, Flag-VEGFR2 Y1175F (gifts from F. Houle), HA-Nrp1 or mutated forms of Nrp1 (Nrp1DC [from J. Raper]; and Nrp1sema, Nrp1Da2, Nrp1Db1, Nrp1Db2, and Nrp1DMAM [from A. Kolodkin]), VSV-PlexinD1, V5-PlexinD1DC (provided by A. Uemura), dominant-negative (DN) PI3K (provided by D. Cantrell), DN Akt (provided by D. Kaplan) or constitutive active (CA) GSK-3b (from A. Kikuchi), and/or different siRNAs (100 pmol). See Supplemental Experimental Procedures for further details on siRNA sequences. In some experiments, neurons were cultured in the presence of VEGFR2 inhibitors SU1438 (0.1 mM, Calbiochem) and Ki8751 (0.1 mM, Calbiochem), anti-VEGFR2 (10 mg/ml, R&D Systems), anti-VEGF (10 mg/ml, R&D Systems), VEGFA 164 (10-100 mm, R&D Systems), VEGFA 120 (100 mm, R&D Systems), VEGFC (100 mm, R&D Systems), VEGFD (100 mm, R&D Systems), Nrp1-Fc (2 mg/ml, R&D Systems), LY294002 (5 mM, Cell Signaling Technology), or Wortmannin (50 nM, Cell Signaling Technology).
Quantification of Axonal Growth and Guidance
After 2-3 days in vitro, cultures were fixed, immunostained with mouse anti-tubulin antibody (1:2000, Sigma-Aldrich) or rabbit anti-GFP antibody (1:500, Torrey Pines) and labeled with Texas Red-X Phalloidin (1:40, Invitrogen). Secondary antibodies were Alexa Fluor 488-conjugated goat anti-mouse IgG (1:500, Interchim Molecular Probes), and Alexa Fluor 488-conjugated goat anti-rabbit IgG (1:400, Interchim Molecular Probes). Nuclei were counterstained with DAPI. The growth and guidance effects were quantified as described (Chauvet et al., 2007) .
Quantitative Fluorescence Determinations Subicular neurons grown for 24 hr in vitro were incubated 2 hr in the presence of Ki8751 (0.1 mM, Calbiochem) prior to stimulation with 10nM Sema3E for 7 min, fixed and immunolabeled using rabbit anti-phosphoY1175-VEGFR2 (Cell Signaling Technology), rabbit anti-phosphoS473-Akt (Cell Signaling Technology), or rabbit anti-phosphoS9-GSK-3a/b (Cell Signaling Technology), and Alexa Fluor 555-conjugated donkey anti-rabbit IgG (Invitrogen Molecular Probes) antibodies. Fluorescent-stained growth cones were imaged with a confocal microscope (Zeiss LSM 510 Meta) equipped with 403 oil Plan-NEOFLUAR objective. Parameters of time interval and gain setting on the camera were adjusted so the brightest areas did not reach saturation, and the same gain and time interval was used to capture all images of any particular staining. The immunofluorescence intensity within the area of the growth cone was measured using the ImageJ software in $15 growth cones for each condition.
Immunoprecipitation and Western Blotting
See Supplemental Experimental Procedures.
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